Literature DB >> 10950748

Which children should receive growth hormone treatment. Cost-benefit analysis is the key.

C J Kelnar1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10950748      PMCID: PMC1718444     

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  24 in total

Review 1.  Four decades of growth hormone therapy for short children: what have we achieved?

Authors:  H J Guyda
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

2.  Pride and prejudice--stature in perspective.

Authors:  C J Kelnar
Journal:  Acta Paediatr Scand Suppl       Date:  1990

3.  Psychosocial outcome of children evaluated for short stature.

Authors:  G D Zimet; R Owens; W Dahms; M Cutler; M Litvene; L Cuttler
Journal:  Arch Pediatr Adolesc Med       Date:  1997-10

4.  What is a normal stimulated growth hormone concentration?

Authors:  M T Dattani; P J Pringle; P C Hindmarsh; C G Brook
Journal:  J Endocrinol       Date:  1992-06       Impact factor: 4.286

5.  Are short normal children at a disadvantage? The Wessex growth study.

Authors:  A B Downie; J Mulligan; R J Stratford; P R Betts; L D Voss
Journal:  BMJ       Date:  1997-01-11

6.  Safety of human growth hormone therapy.

Authors:  E M Ritzén; P Czernichow; M Preece; M Ranke; J M Wit
Journal:  Horm Res       Date:  1993

Review 7.  Growth hormone therapy in Turner syndrome--current uncertainties and future strategies.

Authors:  M D Donaldson
Journal:  Horm Res       Date:  1997

8.  Short stature: a psychosocial burden requiring growth hormone therapy?

Authors:  D E Sandberg; A E Brook; S P Campos
Journal:  Pediatrics       Date:  1994-12       Impact factor: 7.124

9.  Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints.

Authors:  J M Tanner; R H Whitehouse; P C Hughes; F P Vince
Journal:  Arch Dis Child       Date:  1971-12       Impact factor: 3.791

10.  Dose-response curves for treatment with biosynthetic human growth hormone.

Authors:  F Darendeliler; P C Hindmarsh; C G Brook
Journal:  J Endocrinol       Date:  1990-05       Impact factor: 4.286

View more
  2 in total

1.  Lack of Catch-Up Growth with Growth Hormone Treatment in a Child Born Small for Gestational Age Leading to a Diagnosis of Noonan Syndrome with a Pathogenic PTPN11 Variant.

Authors:  Daniel J Olivieri; Lauren J Massingham; Jennifer L Schwab; Jose Bernardo Quintos
Journal:  Case Rep Endocrinol       Date:  2021-06-07

Review 2.  Growth hormone treatment and risk of malignancy.

Authors:  Hyun-Wook Chae; Duk-Hee Kim; Ho-Seong Kim
Journal:  Korean J Pediatr       Date:  2015-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.